CD19 and neoplasm: Specific lysis of only CD19-positive tumor lines confirmed the antigen specificity of both ET190L1-CAR-T cells and ET190L1-AbTCR-T cells while demonstrating comparable cellular cytotoxicity and degranulation (Fig. 3c, Supplementary Fig. S8).